Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases.

Victoria Furer Christien RondaanNancy Agmon-LevinSander van AssenMarc BijlMeliha Crnkic KapetanovicAnnette de ThurahUlf Mueller-LadnerDaphna ParanKaren SchreiberKlaus WarnatzNico M WulffraatOri Elkayam

Published in: RMD open (2021)

In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This position paper summarises the current data on COVID-19 infection in patients with AIIRD and development of vaccines against COVID-19, discusses the aspects of efficacy and safety of vaccination, and proposes preliminary considerations on vaccination against COVID-19 in patients with AIIRD, mainly based on the expert opinion and knowledge on the use of other vaccines in this population of patients.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
oxidative stress
healthcare
newly diagnosed
chronic kidney disease
clinical practice
prognostic factors
drug induced
machine learning
patient reported outcomes
big data
data analysis